Home  »  Stock   »  Roll up the Sleeves! When the bell rang at previou...

Roll up the Sleeves! When the bell rang at previous close Takeda Pharmaceutical Company Limited (TAK) was down -1.74%

Let’s start up with the current stock price of Takeda Pharmaceutical Company Limited (TAK), which is $12.99 to be very precise. The Stock rose vividly during the last session to $13.17 after opening rate of $13.17 while the lowest price it went was recorded $12.965 before closing at $13.22.Recently in News on September 20, 2022, Health Canada approves Takeda’s LIVTENCITY™ (maribavir) the First and Only Treatment for Adults with Post-Transplant Cytomegalovirus (CMV) infection. Takeda Canada Inc. (“Takeda”) is pleased to announce that Health Canada has authorized (Notice of Compliance) LIVTENCITY™ (maribavir) for the treatment of adults with post-transplant cytomegalovirus (CMV) infection/disease who are refractory (with or without genotypic resistance) to one or more prior antiviral therapies.1 Compared to conventionally used antivirals to treat post-transplant CMV, LIVTENCITY offers twice the efficacy1 and more than 10 times less toxicity.1*. You can read further details here

Takeda Pharmaceutical Company Limited had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $15.36 on 02/18/22, with the lowest value was $12.97 for the same time period, recorded on 09/21/22.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Takeda Pharmaceutical Company Limited (TAK) full year performance was -24.56%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Takeda Pharmaceutical Company Limited shares are logging -24.96% during the 52-week period from high price, and -0.49% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $13.05 and $17.31.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2706883 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Takeda Pharmaceutical Company Limited (TAK) recorded performance in the market was -4.70%, having the revenues showcasing -4.84% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 41.38B, as it employees total of 47347 workers.

Analysts verdict on Takeda Pharmaceutical Company Limited (TAK)

During the last month, 5 analysts gave the Takeda Pharmaceutical Company Limited a BUY rating, 2 of the polled analysts branded the stock as an OVERWEIGHT, 7 analysts were recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 14.05, with a change in the price was noted -1.60. In a similar fashion, Takeda Pharmaceutical Company Limited posted a movement of -10.97% for the period of last 100 days, recording 2,547,051 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TAK is recording 0.73 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.68.

Takeda Pharmaceutical Company Limited (TAK): Technical Analysis

Raw Stochastic average of Takeda Pharmaceutical Company Limited in the period of last 50 days is set at 1.30%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 2.33%. In the last 20 days, the company’s Stochastic %K was 16.75% and its Stochastic %D was recorded 26.28%.

Let’s take a glance in the erstwhile performances of Takeda Pharmaceutical Company Limited, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -4.70%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -13.23%, alongside a downfall of -24.56% for the period of the last 12 months. The shares increased approximately by -2.91% in the 7-day charts and went up by -6.01% in the period of the last 30 days. Common stock shares were lifted by -4.84% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts